<DOC>
	<DOCNO>NCT00505336</DOCNO>
	<brief_summary>To investigate whether medicine eplerenone atorvastatin favourable effect diastolic heart failure . Eplerenone drug show beneficial Chronic Heart Failure due pump failure . It increase life expectancy improve symptom patient . It know whether eplerenone might beneficial heart failure normal pump function ( diastolic heart failure ) . Atorvastatin one group cholesterol lower medicine call statin , show reduce cardiovascular disease patient irrespective whether cholesterol level high normal . It know whether atorvastatin also reduce fibrosis heart one cause diastolic heart failure . Study hypothesis 1 . To investigate impact aldosterone antagonism statin therapy marker collagen turnover patient diastolic heart failure . 2 . To assess impact aldosterone antagonism statin therapy marker diastolic dysfunction index clinical well patient diastolic heart failure .</brief_summary>
	<brief_title>The Effect Eplerenone Atorvastatin Markers Collagen Turnover Diastolic Heart Failure</brief_title>
	<detailed_description>Diastolic heart failure significant contributor heart failure syndrome . However , little work do cause diastolic heart failure , contradistinction systolic heart failure , little know aetiology therefore , effective therapy . It generally believe diastolic heart failure represent problem compliance relaxation ventricle . One possible explanation think abnormality collagen structure myocardium . There data hypertensive population well hypertensive experimental model indicate abnormal fibrotic process patient hypertensive heart disease . However , data potential aetiological explanation diastolic heart failure . It possible measure serum marker fibrosis circulate blood . Work area establish reproducibility reliability measurements pro-collagen I pro-collagen III amino-terminal , secreted collagen molecule release fibroblast . These marker analyse several setting , include normal individual , hypertensive population establish heart failure due systolic dysfunction . Recently complete study analysis factor patient proven diastolic heart failure . These data demonstrate increased activity amino terminal pro-collagen III ( PIIINP ) trend towards increase amino-terminal pro-collagen I ( PINP ) . Other relevant marker fibrotic process alter , include metalloproteinase enzyme ( MMP ) tissue inhibitor metalloproteinase enzyme ( TIMP ) These observational data support hypothesis diastolic heart failure may result aggressive uncontrolled myocardial fibrotic process . The purpose project ass whether aldosterone inhibition statin therapy may impact increased level collagen marker , thereby positive influence parameter diastolic function . Aldosterone known potent stimulus fibrotic process therefore likely contributor . Support hypothesis come observation systolic heart failure population administration aldosterone antagonist find benefit especially individual serum evidence heighten fibrotic activity . Statin therapy show reduce myocardial fibrosis rat model . Furthermore , preliminary data present EPHESUS study show great benefit eplerenone receive concomitant statin therapy . We therefore propose analyse impact atorvastatin therapy aldosterone inhibition marker collagen turnover also indices diastolic function marker clinical well . We therefore propose analyse impact aldosterone inhibition statin therapy marker collagen turnover also indices diastolic function marker clinical well .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Diastolic</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Patients diastolic heart failure . Diastolic heart failure define symptom heart failure ejection fraction &gt; 45 % , BNP &gt; 100pg/ml Doppler evidence diastolic dysfunction . Clinically unstable define change diuretic dose month prior enrolment . Evidence significant inflammatory disease hepatic disease metabolic bone disease may alter parameter collagen metabolism . Patients already receive statin , aldosterone eplerenone therapy Pregnant woman woman child bear age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Diastolic heart failure</keyword>
	<keyword>Markers collagen turnover</keyword>
	<keyword>Statins</keyword>
	<keyword>Aldosterone receptor blocker</keyword>
</DOC>